Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201010738 Principal Investigator: Waqar, Saiama
Title: Phase 3, Randomized, Open-Label Study of the Efficacy and Safety of Crizotinib versus Pemetrexed/Cisplatin or Pemetrexed/Carboplatin in Previously Untreated Patients with Non-Squamous Carcinoma of the Lung Harboring a Translocation or Inversion Event Involving the Anaplastic Lymphoma Kinase (Alk) Gene Locus
Phase: III Disease Site: Lung
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is to see whether a new investigational drug called crizotinib can keep cancer from growing for a longer period of time compared to the currently available combination of chemotherapy agents pemetrexed/carboplatin or pemetrexed/cisplatin.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)